Competition and price discounts for a hospital buyer in the anti-infective pharmaceutical market

Journal of Pharmaceutical Finance, Economics and Policy

Volumn 14, Issue 2, 2005, Pages 59-85

  Dusing, Michelle L ^a   Guo, Jeff J ^b   Kelton, Christina M L ^b   Pasquale, Margaret K ^c  

^a HEALTH ALLIANCE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c P and G Pharmaceuticals Inc   (United States)

Author keywords

Anti infective drugs; Competition; Contracting; Nash bargaining; Pharmaceutical prices

Indexed keywords

ALBENDAZOLE; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTHELMINTIC AGENT; ANTIAMEBIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL DERIVATIVE; GENTAMICIN; IVERMECTIN; KANAMYCIN; MACROLIDE; MEBENDAZOLE; NEOMYCIN; PAROMOMYCIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TOBRAMYCIN; TUBERCULOSTATIC AGENT; UNINDEXED DRUG;

ANTIMICROBIAL THERAPY; ARTICLE; COMPETITION; DISEASE MANAGEMENT; DRUG COST; DRUG FORMULARY; DRUG MARKETING; ECONOMIC ASPECT; HOSPITAL PHARMACY; HOSPITAL PURCHASING; HUMAN; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL;

EID: 27644572146     PISSN: 15385698     EISSN: None     Source Type: Journal    
DOI: 10.1300/J371v14n02_06     Document Type: Article

References (19)

1. Bae, J. P. (1997), "Drug Patent Expirations and Speed of Generic Entry," Health Services Research, 32, pp. 87-101.
2. Caves, R. E., M. D. Whinston, and M. A. Hurwitz (1991), "Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry," Breakings Papers: Microeconomics, pp. 1-66.
3. Cook, A. (1998), "How Increased Competition from Generic Drugs Has Affected Prices and Returns in the Pharmaceutical Industry," Congressional Budget Office Report.
4. Ellison, S. F. and C. M. Snyder (2001), "Countervailing Power in Wholesale Pharmaceuticals,quot; MIT Working Paper.
5. Elzinga, K. G. and D. E. Mills (1997), "The Distribution and Pricing of Prescription Drugs," International Journal of the Economics of Business, 4, pp. 287-299.
6. Evans. R. S., S. L. Pestotnik, D. C. Classen, T. P. Clemmer, J. P. Burke, et al. (1998), "Computer Assisted Management Program for Antibiotics and Other Anti-Infective Agents," New England Journal of Medicine (USA), 338, p. 232.
7. Frank, R. G. and D. S. Salkever (1992), "Pricing, Patent Loss and the Market for Pharmaceuticals." Southern Economic Journal, 59, pp. 165-179.
8. Frank, R. G. and D. S. Salkever (1997), "Generic Entry and the Pricing of Pharmaceuticals," Journal of Economics and Management Strategy, 6, pp. 75-90.
9. Grabowski, H. G. and J. M. Vernon (1992), "Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act," Journal of Law and Economics, 21, pp. 331-349.
10. Griliches, Z. and I. Cockburn (1994), "Generics and New Goods in Pharmaceutical Price Indexes," American Economic Review, 84, pp. 1213-1232.
11. Hudson, J. (1992), "Pricing Dynamics in the Pharmaceutical Industry," Applied Economics, 24, pp. 103-112.
12. Hurwitz, M. A. and R. E. Caves (1988), "Persuasion or Information? Promotion and the Shares of Brand Name and Generic Pharmaceuticals," Journal of Law and Economics, 31, pp. 299-320.
13. Lawrence, K. R., H. W. Boucher, M. Adra, and F. J. Massaro (2003), "Development of an Antimicrobial Management Program," American Society of Health-System Pharmacists Midyear Clinical Meeting, 38, p. 633.
14. Lyon, R. A. and Norvell, M. J. (1985), "Effect of a P & T Committee Newsletter on Anti-Infective Prescribing Habits," Hospital Formulary, 20, pp. 742-744.
15. Quintiliani, R. and R. A. Quercia (2003), "How to Create a Therapeutics Committee that is Scientifically and Economically Sound," Formulary, 38, pp. 594-602.
16. Scott Morton, F. M. (1999), "Entry Decisions in the Generic Pharmaceutical Industry," Rand Journal of Economics, 30, pp. 421-440.
17. Snyder, C. M. (1996), "A Dynamic Theory of Countervailing Power," Rand Journal of Economics, 27, pp. 747-769.
18. Snyder, C. M. (1998), "Why Do Larger Buyers Pay Lower Prices? Intense Supplier Competition," Economic Letters, 58, pp. 205-209.
19. Sorensen, A. T. (2001), "Insurer-Hospital Bargaining: Negotiated Discounts in Post-Deregulation Connecticut," University of California at San Diego Department of Economics Working Paper.